Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population displaying cerebrovascular lesions at a point in time
go back to main search page
Accession:CMO:0000925 term browser browse the term
Definition:The number of individuals in a study population which display non-tumorous cerebrovascular lesions at a certain point in time compared to the total number of individuals in the study population, expressed as a percentage. A non-tumorous cerebrovascular lesion is a non-neoplastic, localized, pathological change in the structure of the brain which involves or is caused by a component of the vascular system and/or blood supply of the brain, due to injury or disease; especially one that is circumscribed and well defined.
Synonyms:related_synonym: cerebrovascular lesion prevalence;   stroke prevalence



show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        nervous system disease incidence/prevalence measurement 25
          cerebrovascular lesion incidence/prevalence measurement 4
            percentage of study population displaying cerebrovascular lesions at a point in time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    nervous system measurement 63
      central nervous system measurement 29
        brain measurement 18
          brain lesion measurement 8
            brain non-tumorous lesion measurement 8
              cerebrovascular lesion measurement 7
                cerebrovascular lesion incidence/prevalence measurement 4
                  percentage of study population displaying cerebrovascular lesions at a point in time 0
paths to the root